Literature DB >> 20142841

Bipolar versus monopolar TURP: a prospective controlled study at two urology centers.

D S Engeler1, C Schwab, M Neyer, T Grün, A Reissigl, H-P Schmid.   

Abstract

We compared bipolar and monopolar TURP in a prospective controlled study at two urology centers. The objective of the study was to establish whether there were differences between the two methods with regard to frequency of the transurethral resection (TUR) syndrome, amount of fluid absorbed during surgery, risk of hemorrhage, duration of postoperative catheterization and duration of hospitalization. The duration of surgery, improvement in maximum flow rate (Q-max), residual urine volume, International Prostate Symptom Score (IPSS) and Quality of Life (QoL) score were also compared. Overall, our study showed that there were no major differences between bipolar and monopolar TURP. During follow-up, the clinical efficacy of bipolar TURP has been maintained to the same degree as with the traditional method, with no significant differences for Q-max, IPSS and QoL scores after 1 year. Although the risk of developing TUR syndrome seemed to be smaller with bipolar resection (serum sodium change bipolar versus monopolar: +1.2 versus -0.1 mmol l(-1)), the bleeding tendency with both methods was the same (14.0 g l(-1) hemoglobin loss after 1 day in both groups). On the basis of our findings, we think that the monopolar technique has still a place in TURP.

Entities:  

Mesh:

Year:  2010        PMID: 20142841     DOI: 10.1038/pcan.2010.1

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  8 in total

1.  National trends in surgical therapy for benign prostatic hyperplasia in the United States (2000-2008).

Authors:  Bahaa S Malaeb; Xinhua Yu; A Marshall McBean; Sean P Elliott
Journal:  Urology       Date:  2012-05       Impact factor: 2.649

2.  Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial.

Authors:  Dominik Abt; Livio Mordasini; Lukas Hechelhammer; Thomas M Kessler; Hans-Peter Schmid; Daniel S Engeler
Journal:  BMC Urol       Date:  2014-11-25       Impact factor: 2.264

3.  Transurethral plasmakinetic resection of the prostate is a reliable minimal invasive technique for benign prostate hyperplasia: a meta-analysis of randomized controlled trials.

Authors:  Kai Wang; Yao Li; Jing-Fei Teng; Hai-Yong Zhou; Dan-Feng Xu; Yi Fan
Journal:  Asian J Androl       Date:  2015 Jan-Feb       Impact factor: 3.285

4.  Bipolar versus monopolar resection of benign prostate hyperplasia: a comparison of plasma electrolytes, hemoglobin and TUR syndrome.

Authors:  Meltem Savran Karadeniz; Erdem Bayazit; Omur Aksoy; Emine Aysu Salviz; Tzevat Tefik; Oner Sanli; Mukadder Orhan Sungur; Kamil Mehmet Tugrul
Journal:  Springerplus       Date:  2016-10-07

5.  Outcome of transurethral plasmakinetic vaporization for benign prostatic hyperplasia.

Authors:  Magdy El-Tabey; Ahmed Abo-Taleb; Ashraf Abdelal; Mostafa Mahmod Khalil
Journal:  Int Braz J Urol       Date:  2015 Mar-Apr       Impact factor: 1.541

6.  Bipolar versus monopolar transurethral resection of the prostate for lower urinary tract symptoms secondary to benign prostatic obstruction.

Authors:  Cameron Edwin Alexander; Malo Mf Scullion; Muhammad Imran Omar; Yuhong Yuan; Charalampos Mamoulakis; James Mo N'Dow; Changhao Chen; Thomas Bl Lam
Journal:  Cochrane Database Syst Rev       Date:  2019-12-03

7.  Bipolar transurethral enucleation and resection of the prostate versus bipolar resection of the prostate for prostates larger than 60gr: A retrospective study at a single academic tertiary care center.

Authors:  Yong Wei; Ning Xu; Shao-Hao Chen; Xiao-Dong Li; Qing-Shui Zheng; Yun-Zhi Lin; Xue-Yi Xue
Journal:  Int Braz J Urol       Date:  2016 Jul-Aug       Impact factor: 1.541

Review 8.  An update on transurethral surgery for benign prostatic obstruction.

Authors:  Jonathan Shunming Teo; Yee Mun Lee; Henry Sun Sien Ho
Journal:  Asian J Urol       Date:  2017-06-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.